Oral contraceptives and progressive pulmonary vascular disease.
D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications*; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D009641:Norethynodrel / Q000009:adverse effects; D011247:Pregnancy; D011652:Pulmonary Circulation
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D008656:Mestranol; D008234:Lynestrenol; D009640:Norethindrone